JNJ - CIK 0000200406
JOHNSON & JOHNSON trades as JNJ and has a market capitalization of $573.98 B, making it the #20 largest US-listed company by market value. In its fiscal 2025 annual report the company posted revenue of $94.19B, up 6.0% from the prior year and net income of $26.80B. This page tracks JOHNSON & JOHNSON through 984 SEC filings, with financial statements and metrics updated as new reports are filed.
Over the last 8 fiscal years JOHNSON & JOHNSON's revenue grew from $71.89B to $94.19B, a compound annual growth rate of 3.4%. Net profit margin expanded from 23.0% to 28.5% over the same period - every figure below comes from the company's audited annual filings.
| Filing | Type | Filed |
|---|---|---|
| Institutional holdings | 13F-HR | 2026-05-13 |
| Insider trade | 4 | 2026-05-04 |
| SCHEDULE 13G | - | 2026-05-01 |
| Major company event | 8-K | 2026-04-28 |
| Insider trade | 4 | 2026-04-27 |
| Insider trade | 4 | 2026-04-27 |
| Insider trade | 4 | 2026-04-27 |
| Insider trade | 4 | 2026-04-27 |
Groundbreaking global survey captures the significant patient burden experienced with current standard-of-care bladder cancer treatments, underscoring urgency for continued innovation
Johnson & Johnson Advances the Standard of Calcium Modification with Global Launch of Shockwave™ C2 Aero Coronary IVL Catheter
Johnson & Johnson reinforces its leadership in advancing neuropsychiatry with new portfolio and pipeline data at APA and ASCP
Johnson & Johnson to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference
Johnson & Johnson launches "Generation Fine," a New Movement Encouraging Patients to Expect More from Depression Treatment and Aim for Remission
The largest companies sharing JOHNSON & JOHNSON's SEC industry classification (pharmaceutical preparations).
JOHNSON & JOHNSON (JNJ) has a market capitalization of $573.98 B as of 2026-06-10, ranking #20 among US-listed companies.
JOHNSON & JOHNSON reported revenue of $94.19B for fiscal year 2025, an increase of 6.0% year over year.
Yes. JOHNSON & JOHNSON reported net income of $26.80B in its latest fiscal year.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
Dig into the full income statement, balance sheet, and cash flow statement with annual and quarterly views.